{"id":"https://openalex.org/W335556464","doi":null,"title":"Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.","display_name":"Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.","publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W335556464","mag":"335556464","pmid":"https://pubmed.ncbi.nlm.nih.gov/19529750"},"language":"en","primary_location":{"id":"pmid:19529750","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19529750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS reviews","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072261143","display_name":"Jos\u00e9 A. Mu\u00f1oz-Moreno","orcid":"https://orcid.org/0000-0002-7239-5422","observed_orcids":["https://orcid.org/0000-0002-7239-5422"]},"institutions":[{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 A Mu\u00f1oz-Moreno","raw_affiliation_strings":["Lluita Contra la SIDA Foundation - Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain. jmunoz@flsida.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lluita Contra la SIDA Foundation - Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain. jmunoz@flsida.org","institution_ids":["https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051347769","display_name":"Carmina R. Fumaz","orcid":"https://orcid.org/0000-0003-0838-3395","observed_orcids":["https://orcid.org/0000-0003-0838-3395"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmina R Fumaz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071574595","display_name":"Mar\u00eda Jos\u00e9 Ferrer","orcid":"https://orcid.org/0000-0002-8915-887X","observed_orcids":["https://orcid.org/0000-0002-8915-887X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria J Ferrer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062231410","display_name":"Marian Gonz\u00e1lez-Garc\u00eda","orcid":"https://orcid.org/0000-0002-7450-1161","observed_orcids":["https://orcid.org/0000-0002-7450-1161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marian Gonz\u00e1lez-Garc\u00eda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003961482","display_name":"Jos\u00e9 Molt\u00f3","orcid":"https://orcid.org/0000-0003-4564-1963","observed_orcids":["https://orcid.org/0000-0003-4564-1963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Molt\u00f3","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004612964","display_name":"Eug\u00e8nia Negredo","orcid":"https://orcid.org/0000-0001-5298-1734","observed_orcids":["https://orcid.org/0000-0001-5298-1734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eug\u00e8nia Negredo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028130303","display_name":"Bonaventura Clotet","orcid":"https://orcid.org/0000-0003-3232-4598","observed_orcids":["https://orcid.org/0000-0003-3232-4598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bonaventura Clotet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4424,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.93958653,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"2","first_page":"103","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":1.0},{"id":"https://openalex.org/keywords/neuropsychiatric-symptoms","display_name":"neuropsychiatric symptoms","score":0.953000009059906},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.4259999990463257},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.902999997138977},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8259999752044678},{"id":"https://openalex.org/keywords/neurobehavioral-assessment","display_name":"neurobehavioral assessment","score":0.6610000133514404},{"id":"https://openalex.org/keywords/symptom-management","display_name":"symptom management","score":0.640999972820282},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9826078414916992},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6190528273582458},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5925199389457703},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.5183221101760864},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.5056798458099365},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.46810197830200195},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4027559161186218},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.38239726424217224},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2885146737098694},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.21281856298446655},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16460281610488892},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.09059560298919678}],"mesh":[{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19529750","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19529750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS reviews","raw_type":"Journal Article"},{"id":"mag:335556464","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19529750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W173494530","https://openalex.org/W1594567624","https://openalex.org/W1978540833","https://openalex.org/W1990988855","https://openalex.org/W1991578028","https://openalex.org/W1991864115","https://openalex.org/W1996747410","https://openalex.org/W2011912864","https://openalex.org/W2016702173","https://openalex.org/W2026297831","https://openalex.org/W2031899830","https://openalex.org/W2055351311","https://openalex.org/W2064590924","https://openalex.org/W2081686997","https://openalex.org/W2089182335","https://openalex.org/W2090415722","https://openalex.org/W2090938082","https://openalex.org/W2099746597","https://openalex.org/W2106737113","https://openalex.org/W2127252924","https://openalex.org/W2144420386","https://openalex.org/W2148750104","https://openalex.org/W2258524519","https://openalex.org/W2313885872","https://openalex.org/W2321852728","https://openalex.org/W2322803665","https://openalex.org/W2334561380","https://openalex.org/W2406657642","https://openalex.org/W3191280760"],"related_works":["https://openalex.org/W2734147357","https://openalex.org/W7100450269","https://openalex.org/W2055351311","https://openalex.org/W4384484591","https://openalex.org/W2085377523","https://openalex.org/W4251991714","https://openalex.org/W2607760828","https://openalex.org/W1996747410","https://openalex.org/W2044506291","https://openalex.org/W4249995744"],"abstract_inverted_index":{"The":[0],"non-nucleoside":[1],"analog":[2],"reverse":[3],"transcriptase":[4],"inhibitor":[5],"efavirenz":[6],"is":[7],"one":[8],"of":[9,14,43,79],"the":[10,50,77],"most":[11,51],"common":[12,52],"components":[13],"HAART.":[15],"Neuropsychiatric":[16],"symptoms":[17,27,54],"are":[18,28,83],"frequently":[19],"reported":[20],"in":[21,48],"patients":[22],"taking":[23],"efavirenz-based":[24],"regimens.":[25],"These":[26],"usually":[29],"transient,":[30],"although":[31],"they":[32],"can":[33],"sometimes":[34],"persist":[35],"for":[36],"up":[37],"to":[38,56],"two":[39],"years":[40],"after":[41],"initiation":[42],"treatment.":[44],"This":[45],"review":[46],"describes":[47],"detail":[49],"neuropsychiatric":[53],"related":[55],"efavirenz,":[57],"outlines":[58],"relevant":[59],"and":[60,66],"recent":[61],"findings":[62],"on":[63,71,76],"this":[64],"agent,":[65],"suggests":[67],"possible":[68],"interventions":[69],"based":[70],"neurobehavioral":[72],"results.":[73],"Different":[74],"recommendations":[75],"assessment":[78],"efavirenz-related":[80],"adverse":[81],"events":[82],"also":[84],"provided.":[85]},"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}